Skip to main content
Clinical Trials/ACTRN12612000352808
ACTRN12612000352808
Recruiting
Phase 2

A short term study of safety and glycaemic outcomes in haemodialysis patients with type 2 diabetes treated with metformin

Dr Tilenka Thynne0 sites6 target enrollmentMarch 27, 2012

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Tilenka Thynne
Enrollment
6
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 27, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Dr Tilenka Thynne

Eligibility Criteria

Inclusion Criteria

  • \> 18 years
  • Type 2 Diabetes
  • Receiving haemodialysis 3 times a week for greater than 3 months
  • Patients in which metformin would normally be used if they had normal renal function.

Exclusion Criteria

  • (1\)Any patients in whom metformin would not be used in the setting of normal renal function including: Moderate to severe heart failure, liver failure, alcohol abuse, major psychiatric disorder, acutely unwell or otherwise medically unstable.
  • (2\)Unable or unwilling to self monitor and record blood glucose levels via glucometer readings.
  • (3\)Inability to provide written informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials